Year 2019 / Volume 111 / Number 5
Original
Incidence and characterization of Clostridium difficile in a secondary care hospital in Spain

338-344

DOI: 10.17235/reed.2018.5288/2017

Sara Andrés Lasheras, Inma Martín Burriel, Carmen Aspiroz, Raúl Carlos Mainar Jaime, Pilar Robres, Eloísa Sevilla, Ed Kuijper, Manuel Chirino Trejo, Rosa Bolea,

Abstract
Introduction: Clostridium difficile (C. difficile) is a major nosocomial infectious agent in hospitals. Previous studies have addressed the high proportion of infection episodes that are overlooked in health care facilities. Objective: the main aim of this study was to characterize C. difficile clinical cases that occurred in a secondary care hospital during a five-month period. Material and methods: for this purpose, a total of 137 stool samples from the same number of patients with diarrhea were analyzed for the presence of C. difficile by culture techniques. An enzyme immunoassay (EIA) test for the detection of C. difficile and its toxins was also used in 50 cases (36.5%) for diagnostic purposes. Results: a total of 14 (10.2%) C. difficile isolates were obtained, of which nine (64.3%) were toxigenic. A mean incidence of 3.2 episodes of C. difficile infections (CDI) per 10,000 patients-days was estimated for the study period. Around 56% of the CDI cases were determined as hospital-acquired, whereas 44% originated in the community. Among these, only two episodes (22.2%) were detected in the hospital by the EIA test, which indicated that the hospital CDI detection protocol needed to be revised. One unusual C. difficile isolate was negative for all toxin genes examined and also for the non-toxigenic strain assay, which highlights the need to perform genome sequencing to study its pathogenicity locus insertion site organization. A stable metronidazole-resistant C. difficile strain and three strains showing multidrug resistance were detected in this study, suggesting that C. difficile antimicrobial susceptibility surveillance programs should be established in this health-care facility.
Share Button
New comment
Comments
No comments for this article
References
1. Barbut F, Mastrantonio P, Delmée M, et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13: 1048-57.
2. Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014; 14: 1208-19.
3. Spigaglia P. Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 2016; 3: 23-42.
4. Janezic S, Zidaric V, Pardon B, et al. International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol 2014; 14: 173.
5. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States; 2013 Apr.
6. Wiegand PN, Nathwani D, Wilcox MH, et al. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 2012; 81: 1-14.
7. Asensio A, Bouza E, Grau S, et al. Cost of Clostridium difficile associated diarrhea in Spain. Rev Esp Salud Publica 2013; 87: 25-33.
8. Marín M, Martín A, Alcolea A, et al. First case of autochthonous Clostridium difficile PCR ribotype 027 detected in Spain. Enferm Infecc Microbiol Clin 2014; 32: 355-8.
9. Alcalá Hernández L, Marín Arraza M, Ana Mena Ribas A, et al. Diagnóstico microbiológico de la infección por Clostridium difficile. Madrid (España): Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC); 2015. Informe N.º 53.
10. Alcalá L, Reigadas E, Marín M, et al. Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 2015; 34: 1515-25.
11. European surveillance of Clostridium difficile infections. Stockholm (Sweden): European Centre for Disease Prevention and Control (ECDC); 2015 May. Surveillance protocol version 2.2.
12. Hensgens MPM, Goorhuis A, Dekkers OM, et al. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis 2013; 56: 1108-16.
13. Andrés-Lasheras S, Bolea R, Mainar-Jaime RC, et al. Presence of Clostridium difficile in pig faecal samples and wild animal species associated with pig farms. J Appl Microbiol 2017; 122: 462-72.
14. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2014 Jan. Twenty-Fourth Informational Supplement; CLSI document M100-S24.
15. Spigaglia P, Barbanti F, Mastrantonio P. Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile. Antimicrob Agents Chemother 2008; 52: 770-3.
16. Álvarez-Pérez S, Blanco JL, Martínez-Nevado E, et al. Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii). Vet Microbiol 2014; 169: 218-22.
17. Rupnik M, Janezic S. An update on Clostridium difficile toxinotyping. J Clin Microbiol 2016; 54:13-8.
18. Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010; 48: 770-8.
19. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-20.
20. Martín-Burriel I, Andrés-Lasheras S, Harders F, et al. Molecular analysis of three Clostridium difficile strain genomes isolated from pig farm-related samples. Anaerobe 2017; 48: 224–31.
21. Andrés-Lasheras S, Martín-Burriel I, Mainar-Jaime RC, et al. Preliminary studies on isolates of Clostridium difficile from dogs and exotic pets. BMC Vet Res 2018; 14: 77.
22. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33: 1870-4.
23. Peláez T, Cercenado E, Alcalá L, et al. Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol 2008; 46: 3028-32.
24. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-5.
25. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73.
26. Weber I, Riera E, Déniz C, et al. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Int J Med Microbiol 2013; 303: 128-33.
27. Tenover FC, Baron EJ, Peterson LR, et al. Laboratory diagnosis of Clostridium difficile infection: can molecular amplification methods move us out of uncertainty? J Mol Diagnostics 2011; 13: 573-82.
28. Ramos Martínez A, Ortiz Balbuena J, Asensio Vegas Á, et al. Characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. Rev Esp Enferm Dig 2016; 108: 304–8.
29. Knetsch C, Lawley T, Hensgens M, et al. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Eurosurveillance 2013; 18: 1-11.
30. Janezic S, Indra A, Rattei T, et al. Recombination drives evolution of the Clostridium difficile 16S-23S rRNA intergenic spacer region. PLoS One 2014; 9: e106545.
31. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013; 369: 1195–205.
32. Janezic S, Marín M, Martín A, et al. A new type of toxin A-negative, toxin B-positive Clostridium difficile strain lacking a complete tcdA gene. J Clin Microbiol 2015; 53: 692-5.
33. Janezic S, Dingle K, Didelot X, et al. Comparative genomics of Clostridium difficile toxinotypes. En: 5th International Clostridium difficile Symposium: 19-21-May-2015. Bled (Eslovenia).
34. Knetsch CW, Terveer EM, Lauber C, et al. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol 2012; 12: 1577-85.
35. Dingle KE, Elliott B, Robinson E, et al. Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol 2014; 6: 36-52.
36. Monot M, Eckert C, Lemire A, et al. Clostridium difficile: new insights into the evolution of the pathogenicity locus. Sci Rep 2015; 5: 15023.
37. Rodriguez-Palacios A, Borgmann S, Kline TR, et al. Clostridium difficile in foods and animals: history and measures to reduce exposure. Anim Health Res Rev 2013; 14: 11-29.
38. Koene MGJ, Mevius D, Wagenaar JA, et al. Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect 2012; 18: 778-84.
39. Schneeberg A, Rupnik M, Neubauer H, et al. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe 2012; 18: 484-8.
40. Wetterwik K-J, Trowald-Wigh G, Fernström L-L, et al. Clostridium difficile in faeces from healthy dogs and dogs with diarrhea. Acta Vet Scand 2013; 55: 23.
41. Álvarez-Pérez S, Blanco JL, Peláez T, et al. Faecal shedding of antimicrobial-resistant Clostridium difficile strains by dogs. J Small Anim Pract 2015; 56: 190-5.
42. Spigaglia P, Drigo I, Barbanti F, et al. Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy. Anaerobe 2015; 31: 42-6.
43. Wasels F, Spigaglia P, Barbanti F, et al. Clostridium difficile erm(B)-containing elements and the burden on the in vitro fitness. J Med Microbiol 2013; 62: 1461-7.
44. Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile–associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004; 38: 646-8
Related articles

Special Article

V Spanish Consensus Conference on Helicobacter pylori infection treatment

DOI: 10.17235/reed.2021.8358/2021

Citation tools
Andrés Lasheras S, Martín Burriel I, Aspiroz C, Mainar Jaime R, Robres P, Sevilla E, et all. Incidence and characterization of Clostridium difficile in a secondary care hospital in Spain. 5288/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1211 visits.
This article has been downloaded 230 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/09/2017

Accepted: 14/10/2018

Online First: 20/12/2018

Published: 07/05/2019

Article revision time: 373 days

Article Online First time: 446 days

Article editing time: 584 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology